Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds (Q42540715)

2 November 2017

Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds (English)

1 reference

2 November 2017

Gromer S

1

1 reference

2 November 2017

Arscott LD

2

1 reference

2 November 2017

Williams CH Jr

3

1 reference

2 November 2017

Schirmer RH

4

1 reference

2 November 2017

Becker K

5

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

Journal of Biological Chemistry

2 November 2017

1 reference

2 November 2017

273

1 reference

2 November 2017

20096-20101

1 reference

2 November 2017

32

1 reference

Cloning and sequencing of a human thioredoxin reductase

2 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Mismatch Binding Protein-Based Mutation Detection Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Purification of human thioredoxin reductase: properties and characterization by absorption and circular dichroism spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Interaction of gold(I) with the active site of selenium-glutathione peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Type I iodothyronine deiodinase is a selenocysteine-containing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Thioredoxin reductase activity is decreased by selenium deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Effect of pyridine nucleotide on the oxidative half-reaction of Escherichia coli thioredoxin reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Generating compatible translation initiation regions for heterologous gene expression inEscherichia coliby exhaustive periShine-Dalgarno mutagenesis. Human glutathione reductase cDNA as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Switching kinetic mechanism and putative proton donor by directed mutagenesis of glutathione reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Reductive and oxidative half-reactions of glutathione reductase from Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Intermediates in the catalytic action of lipoyl dehydrogenase (diaphorase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

Update on the human iodothyronine selenodeiodinases, the enzymes regulating the activation and inactivation of thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20096

21 January 2018

Identifiers

DOI

10.1074/JBC.273.32.20096

1 reference

2 November 2017

1 reference